AbbVie Inc.
ABBV · Healthcare · $459.3B
After-hours $259.95-0.03%
Price
$254.8
$260.0
Jul 6, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$17.3B+2.1%
6/'26 vs prev quarter
Company Health
Market Cap$459.3B
Operating Margin+29.8%
Among 19 Drug Manufacturers - General peers
LowMedianHigh
PSR7.1xmedian 3.3xPER72.7xmedian 22.8xABBV's Etentamig Meets Goals in Phase III Multiple Myeloma StudySep 4
AbbVie's Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?Sep 4
Brandywine Trust Co. Takes $25.38 Million Position in AbbVie Inc. $ABBVSep 4
AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (Technical Analysis)Sep 4
AbbVie's Etentamig Delivers 74% Response Rate in Pivotal Cancer TrialSep 3
ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?Sep 3
